Merck KGaA Joins Hands With Busan On Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
South Korea's Busan Metropolitan City will sign a memorandum of understanding with (MoU) Merck KGaA to set up a research and development center in the country's second largest city in a bid to join hands with the German pharma giant in the regenerative medicine sector.